Diabetes mellitus

Acang, 1993, Hypercoagulation in diabetes mellitus, Southeast Asian J Trop Med Public Health, 24, 263

Adelstein, 1979, Haemostatic factors in black and white diabetics, S Afr Med J, 55, 325

Aoki, 1996, Platelet-dependent thrombin generation in patients with diabetes mellitus: effects of glycemic control on coagulability in diabetes, J Am Coll Cardiol, 27, 560, 10.1016/0735-1097(95)00518-8

Aronson, 1997, Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction, Ann Intern Med, 126, 296, 10.7326/0003-4819-126-4-199702150-00006

Barbash, 1993, Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. Investigators of the international tissue plasminogen activator/streptokinase mortality trial, J Am Coll Cardiol, 22, 707, 10.1016/0735-1097(93)90180-9

Baron, 1999, Vascular reactivity, Am J Cardiol, 84, 25J, 10.1016/S0002-9149(99)00354-9

Borsey, 1984, Platelet and coagulation factors in proliferative diabetic retinopathy, J Clin Pathol, 37, 659, 10.1136/jcp.37.6.659

Brownlee, 1983, Nonenzymatic glycosylation reduces the susceptibility of fibrin to degradation by plasmin, Diabetes, 32, 680, 10.2337/diabetes.32.7.680

Calles-Escandon, 1999, Type 2 diabetes: one disease, multiple cardiovascular risk factors, Coron Artery Dis, 10, 23, 10.1097/00019501-199901000-00004

Carmassi, 1992, Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus, Thromb Res, 67, 643, 10.1016/0049-3848(92)90068-L

Carr, 1995, Effect of fibrin structure on plasmin-mediated dissolution digestion of plasma clots, Blood Coagulation Fibrinolysis, 6, 567, 10.1097/00001721-199509000-00011

Carr, 1991, Effect of hyperglycosylated fibrinogen on fibrin assembly, structure and dissolution, Blood, 78, 71a

Collier, 1992, Free radical activity and hemostatic factors in NIDDM patients with and without microalbuminuria, Diabetes, 41, 909, 10.2337/diabetes.41.8.909

Davi, 1992, Thrombin–antithrombin III complexes in type II diabetes mellitus, J Diabetes Complications, 6, 7, 10.1016/1056-8727(92)90042-J

Fujii, 1998, Diminished fibrinolysis and thrombosis: clinical implications for accelerated atherosclerosis, J Atheroscler Thromb, 5, 76, 10.5551/jat1994.5.76

Garcia Frade, 1987, Diabetes mellitus as a hypercoagulable state: its relationship with fibrin fragments and vascular damage, Thromb Res, 47, 533, 10.1016/0049-3848(87)90358-6

Hughes, 1983, Diabetes, a hypercoagulable state? Hemostatic variables in newly diagnosed type 2 diabetic patients, Acta Haematol, 69, 254, 10.1159/000206901

Ishii, 1987, Plasma fibrinopeptide A levels during insulin-induced plasma glucose falls in diabetics, Diabetes Res Clin Pract, 4, 45, 10.1016/S0168-8227(87)80032-3

Jones, 1979, Reduced fibrinogen survival in diabetes mellitus: a reversible phenomenon, J Clin Invest, 63, 485, 10.1172/JCI109326

Jones, 1981, Hematologic alterations of diabetes mellitus, Am J Med, 70, 339, 10.1016/0002-9343(81)90771-3

Khechai, 1997, Effect of advanced glycation end product-modified albumin on tissue factor expression by monocytes. Role of oxidant stress and protein tyrosine kinase activation, Arterioscler, Thromb, Vasc Biol, 17, 2885, 10.1161/01.ATV.17.11.2885

Krishnaswarmi, 1999, Patients with coronary artery disease who present with chest pain have significantly elevated platelet contractile force, Thromb Haemostasis, 82, 162

Lopez, 1999, Measurement of prethrombotic markers in the assessment of acquired hypercoagulable states, Thromb Res, 93, 71, 10.1016/S0049-3848(98)00165-0

Meigs, 2000, Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study, JAMA, J Am Med Assoc, 283, 221, 10.1001/jama.283.2.221

Mirshahi, 1987, Glycosylation of human fibrinogen and fibrin in vitro its consequences on the properties of fibrin(ogen), Thromb Res, 48, 279, 10.1016/0049-3848(87)90440-3

Murakami, 1993, Elevation of factor XIa–alpha 1-antitrypsin complex levels in NIDDM patients with diabetic nephropathy, Diabetes, 42, 233, 10.2337/diabetes.42.2.233

Nagai, 1994, Change of lipoprotein (a) and coagulative or fibrinolytic parameters in diabetic patients with nephropathy, J Atheroscler Thromb, 1, 37, 10.5551/jat1994.1.37

Patrassi, 1982, Contact phase of blood coagulation in diabetes mellitus, Eur J Clin Invest, 12, 307, 10.1111/j.1365-2362.1982.tb02237.x

Patrassi, 1985, Antithrombin III activity and concentration in diabetes mellitus, Thromb Haemostasis, 54, 415, 10.1055/s-0038-1657862

Prayson, 1990, An analysis of outcome following percutaneous transluminal coronary artery angioplasty. An autopsy series, Arch Pathol Lab Med, 114, 1211

Rao, 1999, Activation of the tissue factor pathway of blood coagulation during prolonged hyperglycemia in young healthy men, Diabetes, 48, 1156, 10.2337/diabetes.48.5.1156

Reverter, 1997, Thrombomodulin and induced tissue factor expression on monocytes as markers of diabetic microangiopathy: a prospective study on hemostasis and lipoproteins in insulin-dependent diabetes mellitus, Am J Hematol, 56, 93, 10.1002/(SICI)1096-8652(199710)56:2<93::AID-AJH4>3.0.CO;2-W

Rosove, 1984, Plasma beta-thromboglobulin, platelet factor 4, fibrinopeptide A, and other hemostatic functions during improved, short-term glycemic control in diabetes mellitus, Diabetes Care, 7, 174, 10.2337/diacare.7.2.174

Sacco, 1995, Risk factors and outcomes for ischemic stroke, Neurology, 45, S10

Schafer, 1985, The hypercoagulable states, Ann Intern Med, 102, 814, 10.7326/0003-4819-102-6-814

Schneider, 1996, Synergistic augmentation of expression of plasminogen activator inhibitor type-1 induced by insulin, very-low-density lipoproteins, and fatty acids, Coron Artery Dis, 7, 813, 10.1097/00019501-199611000-00004

Shechter, 2000, Blood glucose and platelet-dependent thrombosis in patients with coronary artery disease, J Am Coll Cardiol, 35, 300, 10.1016/S0735-1097(99)00545-8

Small, 1986, Effect of insulin therapy on coagulation and platelet function in type II (non-insulin-dependent) diabetes mellitus, Haemostasis, 16, 417

Sobel, 1998, Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients: a potential factor predisposing to thrombosis and its persistence, Circulation, 97, 2213, 10.1161/01.CIR.97.22.2213

Vukovich, 1986, Decreased protein C levels in patients with insulin-dependent type I diabetes mellitus, Diabetes, 35, 617, 10.2337/diabetes.35.5.617

Williams, 1980, Electron microscopical studies of vessels in diabetic peripheral neuropathy, J Clin Pathol, 33, 462, 10.1136/jcp.33.5.462

Yagame, 1990, Fibrinolysis in patients with diabetic nephropathy determined by plasmin–alpha 2 plasmin inhibitor complexes in plasma, J Diabetes Complications, 4, 175, 10.1016/0891-6632(90)90018-Z

Yokoyama, 1996, Increased tissue factor pathway inhibitor activity in IDDM patients with nephropathy, Diabetes Care, 19, 441, 10.2337/diacare.19.5.441